Cencora (COR) Competitors $243.20 +2.22 (+0.92%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends COR vs. MCK, CAH, HSIC, PDCO, OMI, PETQ, HLF, NUS, COSM, and HWHShould you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), PetIQ (PETQ), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), and HWH International (HWH). Cencora vs. McKesson Cardinal Health Henry Schein Patterson Companies Owens & Minor PetIQ Herbalife Nu Skin Enterprises Cosmos Health HWH International McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability. Is MCK or COR more profitable? McKesson has a net margin of 0.77% compared to Cencora's net margin of 0.51%. Cencora's return on equity of 266.62% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets McKesson0.77% -207.50% 5.45% Cencora 0.51%266.62%4.20% Does the MarketBeat Community prefer MCK or COR? McKesson received 224 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.33% of users gave McKesson an outperform vote while only 65.40% of users gave Cencora an outperform vote. CompanyUnderperformOutperformMcKessonOutperform Votes96774.33% Underperform Votes33425.67% CencoraOutperform Votes74365.40% Underperform Votes39334.60% Which has more volatility and risk, MCK or COR? McKesson has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Which has higher earnings & valuation, MCK or COR? McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMcKesson$308.95B0.26$3.00B$19.3132.17Cencora$638.56M75.05$1.51B$7.5132.38 Does the media favor MCK or COR? In the previous week, McKesson had 8 more articles in the media than Cencora. MarketBeat recorded 28 mentions for McKesson and 20 mentions for Cencora. Cencora's average media sentiment score of 1.17 beat McKesson's score of 0.98 indicating that Cencora is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 21 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 17 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of MCK or COR? 85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is MCK or COR a better dividend stock? McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.9%. McKesson pays out 14.7% of its earnings in the form of a dividend. Cencora pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years. Do analysts prefer MCK or COR? McKesson presently has a consensus target price of $631.57, indicating a potential upside of 1.65%. Cencora has a consensus target price of $271.20, indicating a potential upside of 11.51%. Given Cencora's higher probable upside, analysts plainly believe Cencora is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.94Cencora 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 SummaryMcKesson beats Cencora on 13 of the 21 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Cencora News Delivered to You Automatically Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COR vs. The Competition Export to ExcelMetricCencoraDrugs, proprietaries, & sundries IndustryMedical SectorNYSE ExchangeMarket Cap$47.92B$14.33B$5.05B$19.84BDividend Yield0.92%1.41%4.97%3.50%P/E Ratio32.3815.6497.3437.73Price / Sales75.058.731,218.4218.01Price / Cash11.1012.3733.5117.90Price / Book60.9512.915.804.86Net Income$1.51B$776.81M$119.07M$985.93M7 Day Performance-0.09%0.82%-1.83%0.45%1 Month Performance2.82%5.13%-3.64%1.05%1 Year Performance22.33%9.45%31.62%24.67% Cencora Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORCencora4.8659 of 5 stars$243.20+0.9%$271.20+11.5%+24.1%$47.92B$638.56M32.3846,000Positive NewsMCKMcKesson4.7828 of 5 stars$621.29+0.9%$631.57+1.7%+37.2%$78.15B$308.95B32.1751,000CAHCardinal Health4.8229 of 5 stars$120.34+1.7%$123.00+2.2%+14.3%$28.64B$224.45B23.4148,900HSICHenry Schein3.4398 of 5 stars$73.73-1.5%$78.89+7.0%+7.5%$9.33B$12.34B30.3425,000Insider TradePDCOPatterson Companies4.8209 of 5 stars$20.06-1.7%$28.30+41.1%-37.4%$1.80B$6.57B10.967,600OMIOwens & Minor4.8028 of 5 stars$11.89-4.2%$18.50+55.6%-37.4%$956.92M$10.33B0.0013,700PETQPetIQ1.8302 of 5 stars$30.98flat$29.67-4.2%N/A$925.99M$1.10B79.441,933HLFHerbalife4.1247 of 5 stars$8.42+8.9%$9.90+17.6%-33.5%$778.11M$5.06B9.909,200NUSNu Skin Enterprises3.6991 of 5 stars$7.49-1.3%$8.88+18.5%-57.3%$377.31M$1.97B0.003,700COSMCosmos Health1.3169 of 5 stars$0.72-2.7%N/A-35.1%$16.81M$53.38M-0.29123HWHHWH InternationalN/A$0.65-11.0%N/AN/A$14.47MN/A0.00N/AGap Down Related Companies and Tools Related Companies MCK Competitors CAH Competitors HSIC Competitors PDCO Competitors OMI Competitors PETQ Competitors HLF Competitors NUS Competitors COSM Competitors HWH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:COR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cencora, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cencora With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.